[Evaluation of local anesthesia with buffered Xylocaine in pleural procedures: The DOULAPLUX study].

IF 0.5 4区医学 Q4 RESPIRATORY SYSTEM

Revue des maladies respiratoires Pub Date : 2024-11-28 DOI:10.1016/j.rmr.2024.11.001

V Guiraud-Chaumeil, H Goussault, A Boudjemaa, F Viñas, V Bonnefoy, Q Gibiot, G Rousseau-Bussac, B Maitre, G Mangiapan

{"title":"[Evaluation of local anesthesia with buffered Xylocaine in pleural procedures: The DOULAPLUX study].","authors":"V Guiraud-Chaumeil, H Goussault, A Boudjemaa, F Viñas, V Bonnefoy, Q Gibiot, G Rousseau-Bussac, B Maitre, G Mangiapan","doi":"10.1016/j.rmr.2024.11.001","DOIUrl":null,"url":null,"abstract":"Introduction: Pleural procedures are painful interventions. While there exist recommendations aimed at preventing pain induced by local anesthesia, they have never been evaluated with regard to the thoracic wall. The objective of this study was to evaluate the effectiveness of buffered lidocaine local anesthesia in pleural procedures.Methods: Descriptive, monocentric, prospective study, including all initial pleural procedures performed in our unit. Pain was assessed 20minutes after the procedure using the VAS (Visual Analog Scale) or the NRS (Numerical Rating Scale).Results: Two hundred and fifty-one patients were included. The procedures included thoracocentesis (58%), pleural or pulmonary biopsy (28%), or drainage (14%). Average pain intensity was 0.6 on a scale of 10. Over two thirds (68%) of patients had a VAS or NRS score of 0, and 91%≤2. Infectious pleuritis, pneumothorax, and drainage were associated with more pain. The pain levels were acceptable (average VAS/NRS scores of 1.3, 1.8, 1.7 respectively).Conclusion: Buffered lidocaine local anesthesia provides excellent pain control for pleural procedures, regardless of their nature. Recommendations regarding local anesthesia apply to the thoracic wall, and their dissemination is essential to reduction of the pain induced by pleural procedures.","PeriodicalId":21548,"journal":{"name":"Revue des maladies respiratoires","volume":" ","pages":""},"PeriodicalIF":0.5000,"publicationDate":"2024-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revue des maladies respiratoires","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.rmr.2024.11.001","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: Pleural procedures are painful interventions. While there exist recommendations aimed at preventing pain induced by local anesthesia, they have never been evaluated with regard to the thoracic wall. The objective of this study was to evaluate the effectiveness of buffered lidocaine local anesthesia in pleural procedures.

Methods: Descriptive, monocentric, prospective study, including all initial pleural procedures performed in our unit. Pain was assessed 20minutes after the procedure using the VAS (Visual Analog Scale) or the NRS (Numerical Rating Scale).

Results: Two hundred and fifty-one patients were included. The procedures included thoracocentesis (58%), pleural or pulmonary biopsy (28%), or drainage (14%). Average pain intensity was 0.6 on a scale of 10. Over two thirds (68%) of patients had a VAS or NRS score of 0, and 91%≤2. Infectious pleuritis, pneumothorax, and drainage were associated with more pain. The pain levels were acceptable (average VAS/NRS scores of 1.3, 1.8, 1.7 respectively).

Conclusion: Buffered lidocaine local anesthesia provides excellent pain control for pleural procedures, regardless of their nature. Recommendations regarding local anesthesia apply to the thoracic wall, and their dissemination is essential to reduction of the pain induced by pleural procedures.

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

Revue des maladies respiratoires 医学-呼吸系统

CiteScore

1.10

自引率

16.70%

发文量

168

审稿时长

4-8 weeks

期刊介绍： La Revue des Maladies Respiratoires est l''organe officiel d''expression scientifique de la Société de Pneumologie de Langue Française (SPLF). Il s''agit d''un média professionnel francophone, à vocation internationale et accessible ici. La Revue des Maladies Respiratoires est un outil de formation professionnelle post-universitaire pour l''ensemble de la communauté pneumologique francophone. Elle publie sur son site différentes variétés d''articles scientifiques concernant la Pneumologie : - Editoriaux, - Articles originaux, - Revues générales, - Articles de synthèses, - Recommandations d''experts et textes de consensus, - Séries thématiques, - Cas cliniques, - Articles « images et diagnostics », - Fiches techniques, - Lettres à la rédaction.